These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 34115782)

  • 21. Synaptic Damage and Its Clinical Correlates in People With Early Huntington Disease: A PET Study.
    Delva A; Michiels L; Koole M; Van Laere K; Vandenberghe W
    Neurology; 2022 Jan; 98(1):e83-e94. PubMed ID: 34663644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regional subcortical shape analysis in premanifest Huntington's disease.
    Tang X; Ross CA; Johnson H; Paulsen JS; Younes L; Albin RL; Ratnanather JT; Miller MI
    Hum Brain Mapp; 2019 Apr; 40(5):1419-1433. PubMed ID: 30376191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Obsessive-Compulsive and Perseverative Behaviors in Huntington's Disease.
    Oosterloo M; Craufurd D; Nijsten H; van Duijn E
    J Huntingtons Dis; 2019; 8(1):1-7. PubMed ID: 30714966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PET Molecular Imaging of Phosphodiesterase 10A: An Early Biomarker of Huntington's Disease Progression.
    Fazio P; Fitzer-Attas CJ; Mrzljak L; Bronzova J; Nag S; Warner JH; Landwehrmeyer B; Al-Tawil N; Halldin C; Forsberg A; Ware J; Dilda V; Wood A; Sampaio C; Varrone A;
    Mov Disord; 2020 Apr; 35(4):606-615. PubMed ID: 31967355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular Imaging Markers to Track Huntington's Disease Pathology.
    Wilson H; De Micco R; Niccolini F; Politis M
    Front Neurol; 2017; 8():11. PubMed ID: 28194132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 18F-FDG PET/CT: an unexpected case of Huntington's disease.
    Michels S; Buchholz HG; Rosar F; Heinrich I; Hoffmann MA; Schweiger S; Tüscher O; Schreckenberger M
    BMC Neurol; 2019 May; 19(1):78. PubMed ID: 31043171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular Imaging in Huntington's Disease.
    Wilson H; Politis M
    Int Rev Neurobiol; 2018; 142():289-333. PubMed ID: 30409256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of prone versus supine 18F-FDG-PET of locally advanced breast cancer: Phantom and preliminary clinical studies.
    Williams JM; Rani SD; Li X; Arlinghaus LR; Lee TC; MacDonald LR; Partridge SC; Kang H; Whisenant JG; Abramson RG; Linden HM; Kinahan PE; Yankeelov TE
    Med Phys; 2015 Jul; 42(7):3801-13. PubMed ID: 26133582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Use of Integrated Positron Emission Tomography-Magnetic Resonance Imaging for Dementia Patients.
    Shepherd TM; Nayak GK
    Top Magn Reson Imaging; 2019 Dec; 28(6):299-310. PubMed ID: 31794502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Striatal metabolism and psychomotor speed as predictors of motor onset in Huntington's disease.
    Herben-Dekker M; van Oostrom JC; Roos RA; Jurgens CK; Witjes-Ané MN; Kremer HP; Leenders KL; Spikman JM
    J Neurol; 2014 Jul; 261(7):1387-97. PubMed ID: 24781835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural Magnetic Resonance Imaging in Huntington's Disease.
    Wilson H; Dervenoulas G; Politis M
    Int Rev Neurobiol; 2018; 142():335-380. PubMed ID: 30409258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TSPO-PET imaging using [18F]PBR06 is a potential translatable biomarker for treatment response in Huntington's disease: preclinical evidence with the p75NTR ligand LM11A-31.
    Simmons DA; James ML; Belichenko NP; Semaan S; Condon C; Kuan J; Shuhendler AJ; Miao Z; Chin FT; Longo FM
    Hum Mol Genet; 2018 Aug; 27(16):2893-2912. PubMed ID: 29860333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined pre-treatment MRI and 18F-FDG PET/CT parameters as prognostic biomarkers in patients with cervical cancer.
    Miccò M; Vargas HA; Burger IA; Kollmeier MA; Goldman DA; Park KJ; Abu-Rustum NR; Hricak H; Sala E
    Eur J Radiol; 2014 Jul; 83(7):1169-1176. PubMed ID: 24767630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in hybrid 18F-FDG PET/MRI in non-small cell lung cancer (NSCLC) lesions: initial results.
    Heusch P; Buchbender C; Köhler J; Nensa F; Beiderwellen K; Kühl H; Lanzman RS; Wittsack HJ; Gomez B; Gauler T; Schuler M; Forsting M; Bockisch A; Antoch G; Heusner TA
    Rofo; 2013 Nov; 185(11):1056-62. PubMed ID: 23860802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of Multimodal Imaging and Clinical Biomarkers in Presymptomatic Carriers of C9orf72 Repeat Expansion.
    De Vocht J; Blommaert J; Devrome M; Radwan A; Van Weehaeghe D; De Schaepdryver M; Ceccarini J; Rezaei A; Schramm G; van Aalst J; Chiò A; Pagani M; Stam D; Van Esch H; Lamaire N; Verhaegen M; Mertens N; Poesen K; van den Berg LH; van Es MA; Vandenberghe R; Vandenbulcke M; Van den Stock J; Koole M; Dupont P; Van Laere K; Van Damme P
    JAMA Neurol; 2020 Aug; 77(8):1008-1017. PubMed ID: 32421156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in striatal dopamine D2 receptor binding in pre-clinical Huntington's disease.
    van Oostrom JC; Dekker M; Willemsen AT; de Jong BM; Roos RA; Leenders KL
    Eur J Neurol; 2009 Feb; 16(2):226-31. PubMed ID: 19138335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Feasibility of simultaneous 18F-FDG PET/MRI for the quantitative volumetric and metabolic measurements of abdominal fat tissues using fat segmentation.
    Im HJ; Paeng JC; Cheon GJ; Kim EE; Lee JS; Goo JM; Kang KW; Chung JK; Lee DS
    Nucl Med Commun; 2016 Jun; 37(6):616-22. PubMed ID: 26836629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microglial activation in presymptomatic Huntington's disease gene carriers.
    Tai YF; Pavese N; Gerhard A; Tabrizi SJ; Barker RA; Brooks DJ; Piccini P
    Brain; 2007 Jul; 130(Pt 7):1759-66. PubMed ID: 17400599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current status of PET imaging in Huntington's disease.
    Pagano G; Niccolini F; Politis M
    Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1171-82. PubMed ID: 26899245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Striatal dopamine D2 receptors, metabolism, and volume in preclinical Huntington disease.
    van Oostrom JC; Maguire RP; Verschuuren-Bemelmans CC; Veenma-van der Duin L; Pruim J; Roos RA; Leenders KL
    Neurology; 2005 Sep; 65(6):941-3. PubMed ID: 16186542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.